CD274 and neoplasm: Taken together, anti-PD1 Abs could not only abrogate the immune suppression and re-activate CD8+ cytotoxic T cells [5], but also activate TAMs to induce an anti-tumor immune response by blocking of PD-L1/PD1 signaling pathway.